跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 13,408 条关于
“TLR7/8 agonist”
全部
13,408
临床试验
5,399
药物
1,671
机构
1,418
资讯
4,920
11个月前
Eikon Therapeutics to Present Phase 2 Data on Novel TLR7/8 Co-Agonist EIK1001 for Advanced NSCLC at ESMO 2025
11个月前
Biodegradable Brain Implants Show Promise in Preventing Glioblastoma Recurrence Through Immune System Reprogramming
去年
Eikon Therapeutics Secures $351M Series D Funding to Advance Melanoma Treatment to Phase III
4年前
Ascendis Pharma A/S Updates on Vision 3x3 Strategy and 2022 Milestones
7个月前
Primmune Therapeutics Raises $8.6M to Advance TLR7 Agonist PRTX007 into Phase 2 Melanoma Trial
3个月前
Biomimetic Polymer Nanomaterials Reprogram the Immunosuppressive Microenvironment in Hepatocellular Carcinoma
3个月前
Precision Immuno-Oncology in Oral Cancer: Biomarkers, Novel Drug Development, and Nanoparticle Platforms
19天前
Engineered Probiotic Carriers Emerge as Living Drug Factories for Tumor-Targeted Therapy
6个月前
Kupando Raises €10 Million to Advance Dual TLR Agonist KUP101 into Phase 1b Clinical Trial
去年
Phase I Trial Investigates Zalifrelimab (UGN-301) Alone and in Combination for Recurrent NMIBC
第 1 页,共 492 页
上一页
下一页